candesartan has been researched along with lisinopril in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 34 (66.67) | 29.6817 |
| 2010's | 12 (23.53) | 24.3611 |
| 2020's | 5 (9.80) | 2.80 |
| Authors | Studies |
|---|---|
| Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Cooper, ME; Mogensen, CE; Neldam, S; Oren, S; Tikkanen, I; Viskoper, R; Watts, RW | 1 |
| Chen, BH | 1 |
| Philips, JC; Scheen, AJ; Weekers, L | 1 |
| Achard, JM; Allard, J; Dalmay, F; Fournier, A; Mazouz, H; Pesteil, F | 1 |
| Alonso, AB; Baltodano, NM; Epstein, M; Preston, RA | 1 |
| Chaturvedi, N; Sjølie, AK | 1 |
| Ahijado, F; Barrio, V; Bernis, C; de Vinuesa, SG; Escalada, P; Espinosa, M; Goicoechea, MA; Gómez, F; Gómez, J; González, C; Luño, J | 1 |
| Jacobsen, P; Parving, HH; Pietraszek, L; Rossing, K | 1 |
| Buikema, H; de Zeeuw, D; Gschwend, S; Henning, RH; Pinto, YM; van Gilst, WH | 1 |
| Eguchi, K; Kario, K; Shimada, K | 1 |
| Bleeke, T; Chen, X; Friedrich, S; Niroomand, F; Tiefenbacher, CP; Vahl, C | 1 |
| Makino, H | 1 |
| Anderson, A; Bertram, D; MacInnis, RJ; Morgan, T | 1 |
| Hainer, JW; Izzo, JL; Kerkering, J; Tou, CK; Weinberg, MS | 1 |
| Bigal, ME; Rapoport, AM | 1 |
| Ando, T; Itoh, M; Joh, T; Kuno, A; Masuda, K; Nakamura, S; Nomura, T; Ogawa, K; Ohara, H; Okamoto, T; Shirai, T; Tang, M; Yamada, T | 1 |
| Ijzerman, RG; Schalkwijk, CG; Schram, MT; Spoelstra-de Man, A; Stehouwer, CD; Twisk, JW; van Dijk, RA; van Ittersum, FJ | 1 |
| Andersen, NH; Eiskjaer, H; Hansen, KW; Helleberg, K; Knudsen, ST; Mogensen, CE; Poulsen, PL; Poulsen, SH | 2 |
| Komuro, I; Kuwabara, Y | 1 |
| Alpers, CE; Chang, A; Finn, LS; Logar, CM; Seliger, SL | 1 |
| Cohen-Solal, A; Dietz, R; Eichhorn, E; Erhardt, L; Hobbs, FD; Krum, H; Maggioni, A; McKelvie, RS; McMurray, J; Piña, IL; Soler-Soler, J; Swedberg, K | 1 |
| Engelman, K | 1 |
| Brouwer, CB; Ijzerman, RG; Kamp, O; Schram, MT; Spoelstra-de Man, AM; Stehouwer, CD; Twisk, JW; van Dijk, RA; van Ittersum, FJ | 1 |
| Hosoya, T; Mitome, J; Miyazaki, Y; Tanno, Y; Utsunomiya, Y; Yamaguchi, Y; Yamamoto, H; Yamamoto, I | 1 |
| Miyagi, R; Okamoto, H; Sugiyama, K; Yayama, K | 1 |
| Bur, A; Derhaschnig, U; Hirschl, MM; Laggner, AN; Woisetschlaeger, C | 1 |
| Stovner, LJ | 1 |
| Bovim, G; Gladwin, AJ; Owen, K; Schrader, H; Stovner, LJ; Tronvik, E; White, LR | 1 |
| Altun, B; Gul Oz, S; Kirkpantur, A; Onal, ED; Onal, IK; Turgan, C | 1 |
| Hayashi, T; Inoue, N; Jin, D; Katayama, H; Kitaura, Y; Miyazaki, M; Muramatsu, M; Takai, S; Tamai, H | 1 |
| Dodson, PM; Wright, AD | 1 |
| Gutiérrez Solís, E; Gutiérrez, E; Huerta, A; Morales, E; Praga, M; Segura, J | 1 |
| Akhmedov, VA; Dolgikh, VT; Dvornikov, VE; Naumov, DV | 1 |
| Bailey, EK; Gales, BJ; Gales, MA; Reed, AN | 1 |
| Cohen, CD; Gaspert, A; Schorn, R | 1 |
| Chen, YL; Chui, H; Hajjar, I; Hart, M; Lipsitz, L; Mack, W; Milberg, W | 1 |
| Bansal, PK; Bisht, R; Prakash, A; Thakur, KS | 1 |
| Fehér, G; Pusch, G | 1 |
| Ekman, I; Lind, L; Lytsy, P; Marttala, K; Nowrouzi, S; Öhagen, P; Östlund, O; Sundström, J | 1 |
| Morris, B; Neher, J; Safranek, S | 1 |
| Dee, E; Goldstein, F; Hajjar, I; Levey, A; McDaniel, D; Obideen, M; Okafor, M; Quyyumi, AA; Shokouhi, M | 1 |
| Hajjar, I; Henley, B; Kulshreshtha, A; Okafor, M; Trammell, A | 1 |
| Hagström, E; Held, C; Lind, L; Lytsy, P; Marttala, K; Neal, B; Nowrouzi, S; Östlund, O; Sundström, J | 1 |
| Tchernev, G | 1 |
10 review(s) available for candesartan and lisinopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Humans; Hypertension; Lisinopril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Retina; Tetrazoles | 2002 |
[Early diagnosis of and therapy for patients with diabetic nephropathy].
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Collagen Type IV; Diabetic Nephropathies; Diet, Protein-Restricted; Humans; Hypoglycemic Agents; Insulin; Life Style; Lisinopril; Tetrazoles | 2004 |
Preventive migraine therapy: what is new.
Topics: Analgesics; Angiotensin-Converting Enzyme Inhibitors; Antidepressive Agents, Second-Generation; Antioxidants; Benzimidazoles; Biphenyl Compounds; Botulinum Toxins; Clonidine; Coenzymes; Fructose; Humans; Lisinopril; Migraine Disorders; Neuroprotective Agents; Petasites; Phytotherapy; Piperazines; Tetrazoles; Topiramate; Triazoles; Ubiquinone | 2004 |
[Ace inhibitors and angiotensin II receptor antagonists for therapy of chronic heart failure].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Lisinopril; Losartan; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2005 |
Diabetic retinopathy and blockade of the renin-angiotensin system: new data from the DIRECT study programme.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Incidence; Lisinopril; Tetrazoles | 2010 |
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Humans; Lisinopril; Migraine Disorders; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2010 |
[Role of antihypertensive drugs in the treatment of migraine].
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Contraindications; Humans; Lisinopril; Migraine Disorders; Renin-Angiotensin System; Tetrazoles; Tryptamines | 2015 |
Clinical Inquiries. How effectively do ACE inhibitors and ARBs prevent migraines?
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Humans; Lisinopril; Migraine Disorders; Tetrazoles | 2018 |
Effects of candesartan on cerebral microvascular function in mild cognitive impairment: Results of two clinical trials.
Topics: Aged; Alzheimer Disease; Carbon Dioxide; Cognitive Dysfunction; Female; Humans; Lisinopril; Male; Randomized Controlled Trials as Topic; Stroke | 2023 |
20 trial(s) available for candesartan and lisinopril
| Article | Year |
|---|---|
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Humans; Hypertension; Lisinopril; Middle Aged; Prospective Studies; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2000 |
[Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy].
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2001 |
Comparative effects on dynamic renal potassium excretion of ACE inhibition versus angiotensin receptor blockade in hypertensive patients with type II diabetes mellitus.
Topics: Administration, Oral; Adult; Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cross-Over Studies; Diabetes Mellitus, Type 2; Humans; Hypertension; Kidney; Lisinopril; Potassium; Tetrazoles; Urodynamics | 2002 |
Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Creatinine; Drug Therapy, Combination; Female; Humans; Kidney Diseases; Lisinopril; Male; Middle Aged; Prospective Studies; Proteinuria; Renin-Angiotensin System; Spain; Tetrazoles; Time Factors; Treatment Outcome | 2002 |
Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Kidney; Lisinopril; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2003 |
Comparison of candesartan with lisinopril on ambulatory blood pressure and morning surge in patients with systemic hypertension.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzothiadiazines; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chi-Square Distribution; Circadian Rhythm; Cross-Over Studies; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Prospective Studies; Sodium Chloride Symporter Inhibitors; Systole; Tetrazoles; Time Factors; Treatment Outcome | 2003 |
Effect of candesartan and lisinopril alone and in combination on blood pressure and microalbuminuria.
Topics: Aged; Aged, 80 and over; Albuminuria; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2004 |
Antihypertensive efficacy of candesartan-lisinopril in combination vs. up-titration of lisinopril: the AMAZE trials.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Tetrazoles; Treatment Outcome; United States | 2004 |
Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized c
Topics: Adult; Aged; Albuminuria; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hydrochlorothiazide; Hypertension; Inflammation; Lisinopril; Male; Middle Aged; Tetrazoles | 2005 |
Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Lisinopril; Male; Middle Aged; Tetrazoles | 2005 |
AMAZE study--less than amazing results.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Humans; Hypertension; Lisinopril; Tetrazoles | 2005 |
Aggressive antihypertensive strategies based on hydrochlorothiazide, candesartan or lisinopril decrease left ventricular mass and improve arterial compliance in patients with type II diabetes mellitus and hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Compliance; Diabetes Mellitus, Type 2; Diastole; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Middle Aged; Organ Size; Systole; Tetrazoles; Ventricular Function, Left | 2006 |
Effects of candesartan and lisinopril on the fibrinolytic system in hypertensive patients.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Female; Fibrinolysis; Humans; Hypertension; Lisinopril; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prospective Studies; Tetrazoles; Tissue Plasminogen Activator | 2007 |
Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Tetrazoles; Treatment Outcome | 2008 |
Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment.
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Collagen; Elastin; Extracellular Matrix; Female; Humans; Hypertension; Lisinopril; Male; Matrix Metalloproteinase 9; Middle Aged; Renin-Angiotensin System; Tetrazoles; Tissue Inhibitor of Metalloproteinase-1 | 2009 |
[The antiproteinuric effect of the blockage of the renin-angiotensin-aldosterone system (RAAS) in obese patients. Which treatment option is the most effective? ].
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Eplerenone; Female; Humans; Lisinopril; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Obesity; Prospective Studies; Proteinuria; Spironolactone; Tetrazoles | 2009 |
Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double-blind randomized clinical trial.
Topics: Age Factors; Aged; Benzimidazoles; Biphenyl Compounds; Blood Pressure Determination; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Sex Factors; Tetrazoles; Treatment Outcome | 2012 |
The Precision HYpertenSIon Care (PHYSIC) study: a double-blind, randomized, repeated cross-over study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biomarkers; Biphenyl Compounds; Blood Pressure; Blood Pressure Determination; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Precision Medicine; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Tetrazoles | 2019 |
Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial.
Topics: Administration, Oral; Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Brain; Cognitive Dysfunction; Female; Humans; Hypertension; Lisinopril; Magnetic Resonance Imaging; Male; Middle Aged; Tetrazoles | 2020 |
Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Lisinopril; Male; Middle Aged; Precision Medicine | 2023 |
21 other study(ies) available for candesartan and lisinopril
| Article | Year |
|---|---|
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Combination treatment effective option for hypertensive, diabetic patients with microalbuminuria.
Topics: Albuminuria; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Lisinopril; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome | 2001 |
Non-AT(1)-receptor-mediated protective effect of angiotensin against acute ischaemic stroke in the gerbil.
Topics: Acute Disease; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Brain Ischemia; Disease Models, Animal; Enalapril; Gerbillinae; Lisinopril; Losartan; Male; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reproducibility of Results; Stroke; Tetrazoles | 2001 |
Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Captopril; Chronic Disease; Coronary Vessels; Disease Models, Animal; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Fatty Acids, Unsaturated; Heart; Heart Failure; Hydrazines; Imidazoles; Indomethacin; Lisinopril; Losartan; Male; Mesenteric Arteries; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Superoxide Dismutase; Sympathetic Nervous System; Tetrazoles; Tetrodotoxin; Vascular Resistance | 2003 |
ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles.
Topics: Acetylcholine; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arterioles; Arteriosclerosis; Benzimidazoles; Biphenyl Compounds; Coronary Disease; Coronary Vessels; Endothelium, Vascular; Fatty Acids, Monounsaturated; Female; Fluvastatin; Histamine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Indoles; Lisinopril; Male; Middle Aged; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitroprusside; Serotonin; Tetrazoles; Vascular Diseases; Vascular Resistance; Vasodilator Agents | 2004 |
Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats.
Topics: Actins; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Body Weight; Chronic Disease; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Fibrosis; Genes, ras; Hydroxyproline; Immunohistochemistry; Lisinopril; Male; Organ Size; Pancreatitis; Peptidyl-Dipeptidase A; Peroxidase; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles | 2005 |
A rare cause of necrotizing and crescentic glomerulonephritis in a young adult male.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Autoantigens; Basement Membrane; Benzimidazoles; Biopsy; Biphenyl Compounds; Collagen Type IV; Diagnosis, Differential; Drug Therapy, Combination; Glomerulonephritis; Hearing Loss, Sensorineural; Hematuria; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunosuppressive Agents; Kidney Glomerulus; Lisinopril; Male; Microscopy, Fluorescence; Nephritis, Hereditary; Nephrotic Syndrome; Prednisone; Proteinuria; Tetrazoles | 2005 |
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Bisoprolol; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Ethanolamines; Evidence-Based Medicine; Guideline Adherence; Heart Failure; Humans; Indoles; Lisinopril; Metoprolol; Mineralocorticoid Receptor Antagonists; Nebivolol; Practice Guidelines as Topic; Propanolamines; Ramipril; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan | 2005 |
Secondary focal segmental glomerulosclerosis following kidney transplantation in a patient with type I diabetes mellitus.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 1; Glomerulosclerosis, Focal Segmental; Humans; Kidney Transplantation; Lisinopril; Male; Proteinuria; Tetrazoles | 2006 |
Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin B2 Receptor Antagonists; Bromodeoxyuridine; Dose-Response Relationship, Drug; Hepatectomy; Hepatocyte Growth Factor; Hepatocytes; Lisinopril; Liver Regeneration; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Time Factors | 2007 |
Migraine prophylaxis with drugs influencing the renin-angiotensin system.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Humans; Lisinopril; Migraine Disorders; Renin-Angiotensin System; Tetrazoles | 2007 |
Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; DNA Mutational Analysis; Drug Resistance; Female; Gene Deletion; Gene Frequency; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Lisinopril; Male; Middle Aged; Migraine Disorders; Mutagenesis, Insertional; Norway; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Risk Factors; Tetrazoles | 2008 |
Involvement of vascular angiotensin II-forming enzymes in the progression of aortic abdominal aneurysms in angiotensin II- infused ApoE-deficient mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Benzimidazoles; Biphenyl Compounds; Chymases; Disease Progression; Lisinopril; Mice; Mice, Knockout; Peptidyl-Dipeptidase A; Tetrazoles | 2009 |
[Preventive strategy for atrial fibrillation in arterial hypertension].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Lisinopril; Male; Middle Aged; Propafenone; Tetrazoles; Treatment Outcome | 2009 |
[Anti-RNA polymerase III antibodies in scleroderma renal crisis].
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Antinuclear; Benzimidazoles; Biopsy; Biphenyl Compounds; Combined Modality Therapy; Diagnosis, Differential; Humans; Kidney; Kidney Failure, Chronic; Kidney Glomerulus; Lisinopril; Male; Plasmapheresis; Renal Dialysis; RNA Polymerase II; Scleroderma, Systemic; Tetrazoles; Thrombotic Microangiopathies; Vasodilator Agents | 2010 |
Beneficial effect of candesartan and lisinopril against haloperidol-induced tardive dyskinesia in rat.
Topics: Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Body Weight; Grooming; Haloperidol; Hand Strength; Interleukin-1beta; Lisinopril; Male; Malondialdehyde; Mastication; Maze Learning; Memory; Motor Activity; Movement Disorders; Nitrites; Oxidative Stress; Rats, Wistar; Rotarod Performance Test; Stereotyped Behavior; Tetrazoles; Tumor Necrosis Factor-alpha | 2015 |
THE NITROSAMINE CONTAMINATION IN BETA BLOCKERS (BISOPROLOL/METOPROLOL), ACE INHIBITORS (LISINOPRIL/PERINDOPRIL), THIAZIDES DIURETICS (HCT), CALCIUM CHANNEL BLOCKERS (AMLODIPINE/FELODIPINE), SARTANS (CANDESARTAN) AND ТHE SUBSEQUENT SKIN CANCER DEVELOPMENT
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bisoprolol; Calcium; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Felodipine; Humans; Lisinopril; Melanoma; Metoprolol; Nitrosamines; Perindopril; Prospective Studies; Skin Neoplasms; Sodium Chloride Symporter Inhibitors; Thiazides | 2023 |